Phoenix Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$93.3M Buy
101,476
+69,419
+217% +$70.4M 0.88% 31
2025
Q4
$24.7M Sell
32,057
-1,299
-4% -$1.24M 0.27% 59
2025
Q3
$19.2M Buy
33,356
+2,024
+6% +$1.51M 0.23% 61
2025
Q2
$24.4M Buy
31,332
+6,443
+26% +$5.01M 0.32% 52
2025
Q1
$20.6M Buy
24,889
+5,852
+31% +$4.87M 0.31% 58
2024
Q4
$14.7M Buy
19,037
+2,096
+12% +$1.74M 0.2% 75
2024
Q3
$15M Sell
16,941
-639
-4% -$574K 0.22% 72
2024
Q2
$15.9M Buy
17,580
+7,258
+70% +$5.81M 0.24% 64
2024
Q1
$8.03M Buy
10,322
+1,484
+17% +$1.06M 0.11% 89
2023
Q4
$5.8M Buy
8,838
+2,488
+39% +$1.45M 0.1% 108
2023
Q3
$3.42M Buy
6,350
+1,083
+21% +$558K 0.06% 137
2023
Q2
$2.47M Buy
5,267
+1,192
+29% +$500K 0.05% 142
2023
Q1
$1.4M Buy
4,075
+2,067
+103% +$697K 0.03% 174
2022
Q4
$737K Buy
2,008
+93
+5% +$33K 0.01% 204
2022
Q3
$632K Buy
1,915
+962
+101% +$305K 0.01% 236
2022
Q2
$309K Buy
+953
New +$286K 0.01% 317

Other funds holding LLY

Phoenix Financial's LLY Position: Q1 2026 in Review

Phoenix Financial increased its Eli Lilly (LLY) stake by 217% in Q1 2026, buying an estimated $70.4M and bringing the position to 101,476 shares worth $93.3M. The position accounts for 0.88% of the portfolio, ranked #31.

Phoenix Financial first reported a position in LLY in Q2 2022 and has held it in 16 quarters since. 4,363 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Phoenix Financial held 101,476 shares of Eli Lilly worth $93.3M as of Q1 2026.
  • Phoenix Financial bought 69,419 Eli Lilly shares in Q1 2026, an estimated $70.4M.
  • Eli Lilly made up 0.88% of Phoenix Financial's portfolio in Q1 2026, its #31 holding.
  • Phoenix Financial first reported a position in Eli Lilly in Q2 2022 and has held it in 16 quarters since.
  • 4,363 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Phoenix Financial's 13F filing for Q1 2026, filed 11 May 2026.